Search Results - David H. Johnson

Refine Results
  1. 1
    Multiple organ dysfunction syndrome: a narrative review

    Multiple organ dysfunction syndrome: a narrative review by David H. Johnson, Irvin Mayers

    Published 2001
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    DRUG FEVER

    DRUG FEVER by David H. Johnson, B. A. Cunha

    Published 1996
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Recent Clinical Advances in Lung Cancer Management

    Recent Clinical Advances in Lung Cancer Management by David H. Johnson, Joan H. Schiller, Paul A. Bunn

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer

    Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer by Steven M. Keller, Sudeshna Adak, Henry Wagner, David H. Johnson

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary

    Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary by Nasser H. Hanna, David H. Johnson, Sarah Temin, Gregory A. Masters

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Breast cancer with skeletal metastases at initial diagnosis: Distinctive clinical characteristics and favorable prognosis

    Breast cancer with skeletal metastases at initial diagnosis: Distinctive clinical characteristics and favorable prognosis by Michael M. Sherry, F. Anthony Greco, David H. Johnson, John D. Hainsworth

    Published 1986
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    An Economic Evaluation of Activated Protein C Treatment for Severe Sepsis

    An Economic Evaluation of Activated Protein C Treatment for Severe Sepsis by Braden Manns, Helen Lee, Christopher J. Doig, David H. Johnson, Cam Donaldson

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group Data

    Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative... by Tien Hoang, Ronghui Xu, Joan H. Schiller, Philip Bonomi, David H. Johnson

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598

    Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598 by Corey J. Langer, Patricia Stephenson, Ann D. Thor, Márk Vangel, David H. Johnson

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study

    Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or withou... by Afshin Dowlati, Robert J. Gray, Alan B. Sandler, Joan H. Schiller, David H. Johnson

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599

    Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4... by Suzanne E. Dahlberg, Alan B. Sandler, Julie R. Brahmer, Joan H. Schiller, David H. Johnson

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: A randomized clinical trial.

    Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: A randomized clinical trial. by Mary M. Velasquez, Kirk von Sternberg, David H. Johnson, Charles Green, Joseph P. Carbonari, Jeffrey T. Parsons

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Randomized Phase II Trial of Paclitaxel Plus Carboplatin or Gemcitabine Plus Cisplatin in Eastern Cooperative Oncology Group Performance Status 2 Non–Small-Cell Lung Cancer Patients: ECOG 1599

    Randomized Phase II Trial of Paclitaxel Plus Carboplatin or Gemcitabine Plus Cisplatin in Eastern Cooperative Oncology Group Performance Status 2 Non–Small-Cell Lung Cancer Patient... by Corey J. Langer, Sigui Li, Joan H. Schiller, William Tester, Bernardo L. Rapoport, David H. Johnson

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Prognostic Models to Predict Survival in Non–Small-Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab

    Prognostic Models to Predict Survival in Non–Small-Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab by Tien Hoang, Suzanne E. Dahlberg, Alan B. Sandler, Julie R. Brahmer, Joan H. Schiller, David H. Johnson

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Induction chemotherapy increases perioperative complications in patients undergoing resection for non–small cell lung cancer

    Induction chemotherapy increases perioperative complications in patients undergoing resection for non–small cell lung cancer by John R. Roberts, Chad Eustis, Russell F. DeVore, David P. Carbone, Hak Choy, David H. Johnson

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Thioredoxin-1 Modulates Transcription of Cyclooxygenase-2 via Hypoxia-Inducible Factor-1α in Non–Small Cell Lung Cancer

    Thioredoxin-1 Modulates Transcription of Cyclooxygenase-2 via Hypoxia-Inducible Factor-1α in Non–Small Cell Lung Cancer by Ildiko Csiki, Kiyoshi Yanagisawa, Nobuhiro Haruki, Sorena Nadaf, Jason D. Morrow, David H. Johnson, David P. Carbone

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Cisplatin-Based Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Implications of Eastern Cooperative Oncology Group 5592, a Randomized Trial

    Cisplatin-Based Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Implications of Eastern Cooperative Oncology Group 5592, a Randomized Trial by Corey J. Langer, Judith Manola, Patricia Bernardo, John W. Kugler, Philip Bonomi, David Cella, David H. Johnson

    Published 2002
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Mitochondrial 3‐hydroxy‐3‐methylglutaryl‐CoA synthase deficiency: urinary organic acid profiles and expanded spectrum of mutations

    Mitochondrial 3‐hydroxy‐3‐methylglutaryl‐CoA synthase deficiency: urinary organic acid profiles and expanded spectrum of mutations by James Pitt, Heidi Peters, Avihu Boneh, Joy Yaplito‐Lee, Stefanie Wieser, Katrin Hinderhofer, David H. Johnson, Johannes Zschocke

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    <i>In Vivo</i> Model of Human Pathogen Infection and Demonstration of Efficacy by an Antimicrobial Pouch for Pacing Devices

    <i>In Vivo</i> Model of Human Pathogen Infection and Demonstration of Efficacy by an Antimicrobial Pouch for Pacing Devices by Linda K. Hansen, Mary B. Brown, David H. Johnson, DONALD F. PALME, Charles J. Love, Rabih O. Darouiche

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Neutrophil-mediated acute lung injury after extracorporeal perfusion

    Neutrophil-mediated acute lung injury after extracorporeal perfusion by David H. Johnson, Dorothy Thomson, Tom Hurst, Kailash Prasad, Thomas W. Wilson, F. Murphy, Anurag Saxena, Irvin Mayers

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: